Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4281 | 1738 | 38.2 | 63% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EMORY EPILEPSY PROGRAM | Address | 20 | 100% | 1% | 9 |
2 | KERALA REGISTRY EPILEPSY PREGNANCY | Address | 17 | 79% | 1% | 11 |
3 | FETAL HYDANTOIN SYNDROME | Author keyword | 14 | 100% | 0% | 7 |
4 | WOMEN WITH EPILEPSY | Author keyword | 13 | 67% | 1% | 12 |
5 | TERATOGENICITY | Author keyword | 12 | 12% | 5% | 90 |
6 | NEUROPHYSIOL EXPT EPILEPTOL | Address | 11 | 100% | 0% | 6 |
7 | FETAL VALPROATE SYNDROME | Author keyword | 11 | 69% | 1% | 9 |
8 | MAJOR CONGENITAL MALFORMATIONS | Author keyword | 8 | 56% | 1% | 10 |
9 | TERATOGENESIS | Author keyword | 8 | 13% | 3% | 53 |
10 | MATERNAL EPILEPSY | Author keyword | 6 | 71% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FETAL HYDANTOIN SYNDROME | 14 | 100% | 0% | 7 | Search FETAL+HYDANTOIN+SYNDROME | Search FETAL+HYDANTOIN+SYNDROME |
2 | WOMEN WITH EPILEPSY | 13 | 67% | 1% | 12 | Search WOMEN+WITH+EPILEPSY | Search WOMEN+WITH+EPILEPSY |
3 | TERATOGENICITY | 12 | 12% | 5% | 90 | Search TERATOGENICITY | Search TERATOGENICITY |
4 | FETAL VALPROATE SYNDROME | 11 | 69% | 1% | 9 | Search FETAL+VALPROATE+SYNDROME | Search FETAL+VALPROATE+SYNDROME |
5 | MAJOR CONGENITAL MALFORMATIONS | 8 | 56% | 1% | 10 | Search MAJOR+CONGENITAL+MALFORMATIONS | Search MAJOR+CONGENITAL+MALFORMATIONS |
6 | TERATOGENESIS | 8 | 13% | 3% | 53 | Search TERATOGENESIS | Search TERATOGENESIS |
7 | MATERNAL EPILEPSY | 6 | 71% | 0% | 5 | Search MATERNAL+EPILEPSY | Search MATERNAL+EPILEPSY |
8 | AXIAL SKELETAL DEFECTS | 6 | 100% | 0% | 4 | Search AXIAL+SKELETAL+DEFECTS | Search AXIAL+SKELETAL+DEFECTS |
9 | EMBRYONIC ARRHYTHMIA | 6 | 100% | 0% | 4 | Search EMBRYONIC+ARRHYTHMIA | Search EMBRYONIC+ARRHYTHMIA |
10 | MECHANISMS OF TERATOGENESIS | 4 | 67% | 0% | 4 | Search MECHANISMS+OF+TERATOGENESIS | Search MECHANISMS+OF+TERATOGENESIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MATERNAL EPILEPSY | 182 | 98% | 3% | 47 |
2 | FETAL HYDANTOIN SYNDROME | 129 | 73% | 6% | 97 |
3 | UK EPILEPSY | 93 | 87% | 3% | 46 |
4 | MAJOR MALFORMATIONS | 66 | 62% | 4% | 68 |
5 | EPILEPTIC MOTHERS | 63 | 78% | 2% | 42 |
6 | PARENTAL EPILEPSY | 56 | 85% | 2% | 29 |
7 | EPILEPTIC WOMEN | 55 | 92% | 1% | 22 |
8 | SPANNING 3 DECADES | 49 | 82% | 2% | 28 |
9 | UPDATE MANAGEMENT ISSUES | 36 | 77% | 1% | 24 |
10 | CALCIUM VALPROATE | 35 | 86% | 1% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts | 2008 | 94 | 80 | 96% |
Teratogenic effects of antiepileptic drugs | 2012 | 33 | 79 | 96% |
Practice Parameter update: Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society | 2009 | 84 | 34 | 97% |
Valproic acid in pregnancy: How much are we endangering the embryo and fetus? | 2009 | 94 | 89 | 79% |
Antiepileptic drug treatment in pregnancy: Changes in drug disposition and their clinical implications | 2013 | 23 | 68 | 76% |
The Australian Register of Antiepileptic Drugs in Pregnancy: Changes over time in the epileptic population | 2014 | 3 | 5 | 100% |
Practice Parameter update: Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society | 2009 | 50 | 35 | 91% |
Antiepileptic drugs and pregnancy outcomes | 2012 | 17 | 149 | 76% |
The impact of seizures on pregnancy and delivery | 2015 | 1 | 23 | 70% |
Pregnancy registries in epilepsy - A consensus statement on health outcomes | 2008 | 42 | 45 | 82% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EMORY EPILEPSY PROGRAM | 20 | 100% | 0.5% | 9 |
2 | KERALA REGISTRY EPILEPSY PREGNANCY | 17 | 79% | 0.6% | 11 |
3 | NEUROPHYSIOL EXPT EPILEPTOL | 11 | 100% | 0.3% | 6 |
4 | N AMER AED PREGNANCY REGISTRY | 6 | 100% | 0.2% | 4 |
5 | RAOUL WALLENBERG | 5 | 55% | 0.3% | 6 |
6 | GENET TERATOL UNIT | 5 | 24% | 1.0% | 17 |
7 | AUSTRALIAN NEUROPHARMACOL | 3 | 100% | 0.2% | 3 |
8 | EPILEPSY CLIN | 2 | 14% | 0.9% | 16 |
9 | EMORY EPILEPSY MONITORING UNIT | 2 | 67% | 0.1% | 2 |
10 | SECT MED STAT BIOMETRY G MACCACARO | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000147165 | HARVARD NEUROENDOCRINE UNIT//CATAMENIAL EPILEPSY//HYPOSEXUALITY |
2 | 0.0000110455 | SUICIDE ATTEMPT DURING PREGNANCY//PREGNANCY AGE//HUMAN GENET TERATOL |
3 | 0.0000103893 | INFANT DOSE//DEGRA//PREGNANCY POSTPARTUM MOOD DISORDERS PROGRAM |
4 | 0.0000096219 | ROSS STUDIES NEURAL BIRTH DEFECTS//PRENATAL DIAZEPAM//NEUROBEHAVIORAL TERATOGENICITY |
5 | 0.0000088095 | EMBRYONIC STEM CELL TEST//HLTH RISK ANAL TOXICOL GRAT//ALTERNATIVE TEST METHOD |
6 | 0.0000086083 | STAVANGER NEUROL UNIT//10 11 EPOXIDE//A1298C MUTATION |
7 | 0.0000080233 | EMBRYOL TERATOL//MATERNAL IMMUNE STIMULATION//INBORN ANOMALIES |
8 | 0.0000078482 | EXPT TERATOL UNIT//BOUINS FLUID//GREY ZONE ANOMALIES |
9 | 0.0000076728 | LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE |
10 | 0.0000062953 | VALPROIC ACID//VALPROATE//TRANS 2 EN VALPROATE |